Martin Shkreli, 10% Owner at KALOBIOS PHARMACEUTICALS INC (KBIO), bought 1,211,115 shares at $1.43 ($1.6M) on 2015-11-16, disclosed to the SEC on 2015-11-18.
Open-market purchase of $1.6M KBIO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.61 | 500,169 | $305K | 18.7% |
| 2 | $1.43 | 97,269 | $139K | 8.5% |
| 3 | $1.93 | 606,677 | $1.2M | 71.7% |
| 4 | $2.43 | 7,000 | $17K | 1.0% |
| Total | $1.35 avg | 1,211,115 | $1.6M | 100% |
| Filing → |
| KBIO | BUY | 2015-11-23 | $94K | — | Filing → |
| KBIO | BUY | 2015-11-19 | $889K | — | Filing → |
| RTRX | SELL | 2014-11-24 | $10.4M | — | Filing → |